- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
My publications
Filter publications
235 publications
2020
Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes.
Frontiers in medicine
PubMed • Publisher's site2020
Effects of 100 % oxygen during exercise in patients with interstitial lung disease.
Respiratory physiology & neurobiology
PubMed • Publisher's site2020
Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study.
New microbes and new infections
PubMed • Publisher's site2020
Growth Hormone-Releasing Hormone in Lung Physiology and Pulmonary Disease
Cells
PubMed • Publisher's site2020
Health and Economy in COVID-19 Era: A Plan for Reconstituting Long-Term Economic Security.
Frontiers in public health
PubMed • Publisher's site